Skip to main content

Stem Cell Transplantation clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for
  • Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant

    Sorry, not currently recruiting here

    This study is a Phase 2 multicenter study with a Safety Lead-in evaluating safety and efficacy of MT-401 administration to patients with AML, who have received their first allogeneic HSCT. The dose administered is 50 x 106 cells (flat dosing).

    at UCLA

Last updated: